摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[[Diphenylphosphanylmethyl(diphenyl)-lambda5-phosphanylidene]amino]-2,3,5,6-tetrafluorobenzamide | 215873-27-1

中文名称
——
中文别名
——
英文名称
4-[[Diphenylphosphanylmethyl(diphenyl)-lambda5-phosphanylidene]amino]-2,3,5,6-tetrafluorobenzamide
英文别名
4-[[diphenylphosphanylmethyl(diphenyl)-λ5-phosphanylidene]amino]-2,3,5,6-tetrafluorobenzamide
4-[[Diphenylphosphanylmethyl(diphenyl)-lambda5-phosphanylidene]amino]-2,3,5,6-tetrafluorobenzamide化学式
CAS
215873-27-1
化学式
C32H24F4N2OP2
mdl
——
分子量
590.496
InChiKey
ZGQRSUOZFOVVDI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.1
  • 重原子数:
    41
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.03
  • 拓扑面积:
    55.4
  • 氢给体数:
    1
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    二(氰基苯)二氯化钯4-[[Diphenylphosphanylmethyl(diphenyl)-lambda5-phosphanylidene]amino]-2,3,5,6-tetrafluorobenzamide二氯甲烷 为溶剂, 以78.1%的产率得到dichloropalladium;4-[[diphenylphosphanylmethyl(diphenyl)-λ5-phosphanylidene]amino]-2,3,5,6-tetrafluorobenzamide
    参考文献:
    名称:
    Retention of Inhibitory Potency of an ACE Inhibitor Conjugated with Rh(III) and Pd(II) (Iminophosphorano)phosphines. Synthesis and X-ray Structural Investigations
    摘要:
    Succinimido, amido, and ester functionalized tetrafluoroaryl azides selectively oxidize bisdiphenylphosphinomethane at one of the P(III) centers giving (iminophosphorano)phosphines 6, 7, and 8 respectively in high yields. Succinimido functionalized perfluoroaryl azido (iminophosphorano)phosphine is attached to angiotensin converting enzyme (ACE) inhibitor, lisinopril at one end, leaving the other end for chelation to Rh(III) and Pd(II) precursors including radioactive analogues establishing the hetero-bifunctionality for potential in vivo tracking of the radiotracer. The measurement of inhibitory potency of lisinopril-metal conjugates (Rh and Pd), modified through the primary amine reveals an increase in inhibitory potency, although small, retaining the target potential of native lisinopril toward specific biological sites. However, direct complexation utilizing the carboxylic groups of lisinopril with a Cu precursor resulted in the reduction of inhibitory potency from nM to mu M levels rendering it less useful for applications as an ACE inhibitor. Single-crystal X-ray structural investigation of the Rh(III) perfluoroaryl (iminophosphorano)phosphine complex 12 shows a distorted mer octahedral configuration with two ligands per metal center and only one of the phosphiniminato nitrogen atom coordinating to the metal. Pd(II) complex 18 reveals that the metal is bound to the iminato nitrogen atom and the P(III) center via cis disposition to form a five-membered ring. X-ray data for 12: triclinic, P-l, 11.570 (6) Angstrom b = 13.668 Angstrom (7) c = 20.709 (10) Angstrom, alpha = 86.068 (10), beta = 83.774 (10), gamma = 83.503 (10) a = 3229.6 (3) Angstrom(3), Z= 2, R = 0.028, R-w, 0.050. X-ray data for 18: triclinic, P-1, a = 11.457 (3) Angstrom, b = 12.223 (3) Angstrom, c = 13.219 (4) Angstrom, alpha = 89.98 (20), beta = 73.710 (20), gamma = 69.980 (20), V = 1665.7 (8) Angstrom(3), Z = 2, R = 0.024, R-w = 0.031.
    DOI:
    10.1021/ja9802403
  • 作为产物:
    描述:
    4-叠氮基-2,3,5,6-四氟苯甲酰胺双二苯基膦甲烷甲苯 为溶剂, 反应 3.0h, 以78.5%的产率得到4-[[Diphenylphosphanylmethyl(diphenyl)-lambda5-phosphanylidene]amino]-2,3,5,6-tetrafluorobenzamide
    参考文献:
    名称:
    Retention of Inhibitory Potency of an ACE Inhibitor Conjugated with Rh(III) and Pd(II) (Iminophosphorano)phosphines. Synthesis and X-ray Structural Investigations
    摘要:
    Succinimido, amido, and ester functionalized tetrafluoroaryl azides selectively oxidize bisdiphenylphosphinomethane at one of the P(III) centers giving (iminophosphorano)phosphines 6, 7, and 8 respectively in high yields. Succinimido functionalized perfluoroaryl azido (iminophosphorano)phosphine is attached to angiotensin converting enzyme (ACE) inhibitor, lisinopril at one end, leaving the other end for chelation to Rh(III) and Pd(II) precursors including radioactive analogues establishing the hetero-bifunctionality for potential in vivo tracking of the radiotracer. The measurement of inhibitory potency of lisinopril-metal conjugates (Rh and Pd), modified through the primary amine reveals an increase in inhibitory potency, although small, retaining the target potential of native lisinopril toward specific biological sites. However, direct complexation utilizing the carboxylic groups of lisinopril with a Cu precursor resulted in the reduction of inhibitory potency from nM to mu M levels rendering it less useful for applications as an ACE inhibitor. Single-crystal X-ray structural investigation of the Rh(III) perfluoroaryl (iminophosphorano)phosphine complex 12 shows a distorted mer octahedral configuration with two ligands per metal center and only one of the phosphiniminato nitrogen atom coordinating to the metal. Pd(II) complex 18 reveals that the metal is bound to the iminato nitrogen atom and the P(III) center via cis disposition to form a five-membered ring. X-ray data for 12: triclinic, P-l, 11.570 (6) Angstrom b = 13.668 Angstrom (7) c = 20.709 (10) Angstrom, alpha = 86.068 (10), beta = 83.774 (10), gamma = 83.503 (10) a = 3229.6 (3) Angstrom(3), Z= 2, R = 0.028, R-w, 0.050. X-ray data for 18: triclinic, P-1, a = 11.457 (3) Angstrom, b = 12.223 (3) Angstrom, c = 13.219 (4) Angstrom, alpha = 89.98 (20), beta = 73.710 (20), gamma = 69.980 (20), V = 1665.7 (8) Angstrom(3), Z = 2, R = 0.024, R-w = 0.031.
    DOI:
    10.1021/ja9802403
点击查看最新优质反应信息

文献信息

  • Retention of Inhibitory Potency of an ACE Inhibitor Conjugated with Rh(III) and Pd(II) (Iminophosphorano)phosphines. Synthesis and X-ray Structural Investigations
    作者:Raghoottama S. Pandurangi、Kattesh V. Katti、Loreen Stillwell、Charles L. Barnes
    DOI:10.1021/ja9802403
    日期:1998.11.1
    Succinimido, amido, and ester functionalized tetrafluoroaryl azides selectively oxidize bisdiphenylphosphinomethane at one of the P(III) centers giving (iminophosphorano)phosphines 6, 7, and 8 respectively in high yields. Succinimido functionalized perfluoroaryl azido (iminophosphorano)phosphine is attached to angiotensin converting enzyme (ACE) inhibitor, lisinopril at one end, leaving the other end for chelation to Rh(III) and Pd(II) precursors including radioactive analogues establishing the hetero-bifunctionality for potential in vivo tracking of the radiotracer. The measurement of inhibitory potency of lisinopril-metal conjugates (Rh and Pd), modified through the primary amine reveals an increase in inhibitory potency, although small, retaining the target potential of native lisinopril toward specific biological sites. However, direct complexation utilizing the carboxylic groups of lisinopril with a Cu precursor resulted in the reduction of inhibitory potency from nM to mu M levels rendering it less useful for applications as an ACE inhibitor. Single-crystal X-ray structural investigation of the Rh(III) perfluoroaryl (iminophosphorano)phosphine complex 12 shows a distorted mer octahedral configuration with two ligands per metal center and only one of the phosphiniminato nitrogen atom coordinating to the metal. Pd(II) complex 18 reveals that the metal is bound to the iminato nitrogen atom and the P(III) center via cis disposition to form a five-membered ring. X-ray data for 12: triclinic, P-l, 11.570 (6) Angstrom b = 13.668 Angstrom (7) c = 20.709 (10) Angstrom, alpha = 86.068 (10), beta = 83.774 (10), gamma = 83.503 (10) a = 3229.6 (3) Angstrom(3), Z= 2, R = 0.028, R-w, 0.050. X-ray data for 18: triclinic, P-1, a = 11.457 (3) Angstrom, b = 12.223 (3) Angstrom, c = 13.219 (4) Angstrom, alpha = 89.98 (20), beta = 73.710 (20), gamma = 69.980 (20), V = 1665.7 (8) Angstrom(3), Z = 2, R = 0.024, R-w = 0.031.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐